134 related articles for article (PubMed ID: 25517868)
1. Analysis of the distribution and expression of claudin-1 tight junction protein in the oral cavity.
Ouban A; Ahmed A
Appl Immunohistochem Mol Morphol; 2015 Jul; 23(6):444-8. PubMed ID: 25517868
[TBL] [Abstract][Full Text] [Related]
2. Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma.
Dos Reis PP; Bharadwaj RR; Machado J; Macmillan C; Pintilie M; Sukhai MA; Perez-Ordonez B; Gullane P; Irish J; Kamel-Reid S
Cancer; 2008 Dec; 113(11):3169-80. PubMed ID: 18991282
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of the tight junction molecules claudin-1 and zonula occludens-1 mediates cell growth and invasion in oral squamous cell carcinoma.
Babkair H; Yamazaki M; Uddin MS; Maruyama S; Abé T; Essa A; Sumita Y; Ahsan MS; Swelam W; Cheng J; Saku T
Hum Pathol; 2016 Nov; 57():51-60. PubMed ID: 27436828
[TBL] [Abstract][Full Text] [Related]
4. The prognostic role of claudins -1 and -4 in oral squamous cell carcinoma.
DE Vicente JC; Fernández-Valle Á; Vivanco-Allende B; Santamarta TR; Lequerica-Fernández P; Hernández-Vallejo G; Allonca-Campa E
Anticancer Res; 2015 May; 35(5):2949-59. PubMed ID: 25964581
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Claudin-1 is Associated with Advanced Clinical Stage and Invasive Pathologic Characteristics of Oral Squamous Cell Carcinoma.
Sappayatosok K; Phattarataratip E
Head Neck Pathol; 2015 Jun; 9(2):173-80. PubMed ID: 25078758
[TBL] [Abstract][Full Text] [Related]
6. Oral squamous cell carcinoma: status of tight junction claudins in the different histopathological patterns and relationship with clinical parameters. A tissue-microarray-based study of 136 cases.
Lourenço SV; Coutinho-Camillo CM; Buim ME; Pereira CM; Carvalho AL; Kowalski LP; Soares FA
J Clin Pathol; 2010 Jul; 63(7):609-14. PubMed ID: 20591911
[TBL] [Abstract][Full Text] [Related]
7. Claudin-1 expression in squamous cell carcinomas of different organs: comparative study of cancerous tissues and normal controls.
Ouban A; Hamdan H; Hakam A; Ahmed AA
Int J Surg Pathol; 2012 Apr; 20(2):132-8. PubMed ID: 21997594
[TBL] [Abstract][Full Text] [Related]
8. Claudin-7 down-regulation is an important feature in oral squamous cell carcinoma.
Lourenço SV; Coutinho-Camillo CM; Buim ME; de Carvalho AC; Lessa RC; Pereira CM; Vettore AL; Carvalho AL; Fregnani JH; Kowalski LP; Soares FA
Histopathology; 2010 Nov; 57(5):689-98. PubMed ID: 21083599
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 receptor antagonist (IL1RN) is associated with suppression of early carcinogenic events in human oral malignancies.
Shiiba M; Saito K; Yamagami H; Nakashima D; Higo M; Kasamatsu A; Sakamoto Y; Ogawara K; Uzawa K; Takiguchi Y; Tanzawa H
Int J Oncol; 2015 May; 46(5):1978-84. PubMed ID: 25738940
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of gelsolin-like actin-capping protein expression in oral carcinogenesis: an immunohistochemical study of premalignant and malignant lesions of the oral cavity.
Nomura H; Uzawa K; Ishigami T; Kouzu Y; Koike H; Ogawara K; Siiba M; Bukawa H; Yokoe H; Kubosawa H; Tanzawa H
BMC Cancer; 2008 Feb; 8():39. PubMed ID: 18237446
[TBL] [Abstract][Full Text] [Related]
11. [Ki-67 and claudin-1 expression in hyperplasia, oral squamous inthraepithelial neoplasia and oral squamous cell carcinoma].
Ivina AA; Babichenko II; Rabinovich OF; Togonidze AA
Stomatologiia (Mosk); 2014; 93(1):31-3. PubMed ID: 24576965
[TBL] [Abstract][Full Text] [Related]
12. Repression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinoma.
Liu SL; Zhong SS; Ye DX; Chen WT; Zhang ZY; Deng J
J Oral Pathol Med; 2013 Nov; 42(10):761-8. PubMed ID: 23651229
[TBL] [Abstract][Full Text] [Related]
13. Alterations in the expression of EMT-related proteins claudin-1, claudin-4 and claudin-7, E-cadherin, TWIST1 and ZEB1 in oral lichen planus.
Hämäläinen L; Soini Y; Pasonen-Seppänen S; Siponen M
J Oral Pathol Med; 2019 Sep; 48(8):735-744. PubMed ID: 31228209
[TBL] [Abstract][Full Text] [Related]
14. The expression of the receptor for glycation endproducts (RAGE) in oral squamous cell carcinomas.
Landesberg R; Woo V; Huang L; Cozin M; Lu Y; Bailey C; Qu W; Pulse C; Schmidt AM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 May; 105(5):617-24. PubMed ID: 18206396
[TBL] [Abstract][Full Text] [Related]
15. Site-specific gene expression patterns in oral cancer.
Frohwitter G; Buerger H; Korsching E; van Diest PJ; Kleinheinz J; Fillies T
Head Face Med; 2017 May; 13(1):6. PubMed ID: 28486965
[TBL] [Abstract][Full Text] [Related]
16. Podoplanin expression in tumor-free resection margins of oral squamous cell carcinomas: an immunohistochemical and fractal analysis study.
Margaritescu C; Raica M; Pirici D; Simionescu C; Mogoanta L; Stinga AC; Stinga AS; Ribatti D
Histol Histopathol; 2010 Jun; 25(6):701-11. PubMed ID: 20376776
[TBL] [Abstract][Full Text] [Related]
17. Gene expression changes in initiation and progression of oral squamous cell carcinomas revealed by laser microdissection and oligonucleotide microarray analysis.
Sumino J; Uzawa N; Okada N; Miyaguchi K; Mogushi K; Takahashi K; Sato H; Michikawa C; Nakata Y; Tanaka H; Amagasa T
Int J Cancer; 2013 Feb; 132(3):540-8. PubMed ID: 22740306
[TBL] [Abstract][Full Text] [Related]
18. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.
Uzawa K; Ono K; Suzuki H; Tanaka C; Yakushiji T; Yamamoto N; Yokoe H; Tanzawa H
Clin Cancer Res; 2002 Mar; 8(3):828-35. PubMed ID: 11895916
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profile of oral squamous cell carcinomas from Sri Lankan betel quid users.
Suhr ML; Dysvik B; Bruland O; Warnakulasuriya S; Amaratunga AN; Jonassen I; Vasstrand EN; Ibrahim SO
Oncol Rep; 2007 Nov; 18(5):1061-75. PubMed ID: 17914555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
